Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blair Simpson

Showing results (141-150 of 204) with videos related to

Pageof 21
Sort By:
The Journal of Clinical Psychiatry|March 6, 2018
Effects of Rapastinel (Formerly GLYX-13) on Serum Brain-Derived Neurotrophic Factor in Obsessive-Compulsive DisorderOmer Linkovski, Hanyang Shen, Jordana Zwerling, et al.
Journal of Clinical Psychopharmacology|December 12, 2018
Exploring Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Extinction Learning-Based Treatment Outcome in Obsessive-Compulsive Disorder: A Pilot StudyOmer Linkovski, Michael G Wheaton, Jordana Zwerling, et al.
Depression and Anxiety|March 11, 2010
Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-VJames F Leckman, Damiaan Denys, H Blair Simpson, et al.
BMJ Open Quality|July 19, 2022
Design and implementation of a novel patient-centered empowerment approach for pain optimisation in children undergoing major surgeryVidya Chidambaran, Blair Simpson, Laura Brower, et al.
Behavior Therapy|June 26, 2018
Acceptability, Feasibility, and Effectiveness of Internet-Based Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in New YorkSapana R Patel, Michael G Wheaton, Erik Andersson, et al.
The American Journal of Psychiatry|December 31, 2004
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorderEdna B Foa, Michael R Liebowitz, Michael J Kozak, et al.
Journal of Psychiatry & Neuroscience : JPN|June 21, 2017
Basolateral amygdala-ventromedial prefrontal cortex connectivity predicts cognitive behavioural therapy outcome in adults with obsessive-compulsive disorderMiquel A Fullana, Xi Zhu, Pino Alonso, et al.
Psychiatry Research|May 11, 2021
Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorderChristopher Pittenger, Brian P Brennan, Lorrin Koran, et al.
Depression and Anxiety|July 27, 2004
Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorderH Blair Simpson, Michael R Liebowitz, Edna B Foa, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 26, 2002
Fluoxetine in children and adolescents with OCD: a placebo-controlled trialMichael R Liebowitz, Samuel M Turner, John Piacentini, et al.
Pageof 21

Showing results (141-150 of 204) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Psychiatry|March 6, 2018
Effects of Rapastinel (Formerly GLYX-13) on Serum Brain-Derived Neurotrophic Factor in Obsessive-Compulsive DisorderOmer Linkovski, Hanyang Shen, Jordana Zwerling, et al.
Journal of Clinical Psychopharmacology|December 12, 2018
Exploring Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Extinction Learning-Based Treatment Outcome in Obsessive-Compulsive Disorder: A Pilot StudyOmer Linkovski, Michael G Wheaton, Jordana Zwerling, et al.
Depression and Anxiety|March 11, 2010
Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-VJames F Leckman, Damiaan Denys, H Blair Simpson, et al.
BMJ Open Quality|July 19, 2022
Design and implementation of a novel patient-centered empowerment approach for pain optimisation in children undergoing major surgeryVidya Chidambaran, Blair Simpson, Laura Brower, et al.
Behavior Therapy|June 26, 2018
Acceptability, Feasibility, and Effectiveness of Internet-Based Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in New YorkSapana R Patel, Michael G Wheaton, Erik Andersson, et al.
The American Journal of Psychiatry|December 31, 2004
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorderEdna B Foa, Michael R Liebowitz, Michael J Kozak, et al.
Journal of Psychiatry & Neuroscience : JPN|June 21, 2017
Basolateral amygdala-ventromedial prefrontal cortex connectivity predicts cognitive behavioural therapy outcome in adults with obsessive-compulsive disorderMiquel A Fullana, Xi Zhu, Pino Alonso, et al.
Psychiatry Research|May 11, 2021
Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorderChristopher Pittenger, Brian P Brennan, Lorrin Koran, et al.
Depression and Anxiety|July 27, 2004
Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorderH Blair Simpson, Michael R Liebowitz, Edna B Foa, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 26, 2002
Fluoxetine in children and adolescents with OCD: a placebo-controlled trialMichael R Liebowitz, Samuel M Turner, John Piacentini, et al.
Pageof 21